HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Total Mouthwash Debut Makes “Complete Regimen”

This article was originally published in The Rose Sheet

Executive Summary

Colgate-Palmolive rounds out its Colgate Total line with Pro-Shield mouthwash, bowing in the firm’s second quarter. Firm plans to support the launch with a “very robust” integrated marketing campaign featuring talk-show host Kelly Ripa.

You may also be interested in...



Colgate Builds Domestic Oral Care With Freshening, Sensitivity Pastes

Colgate-Palmolive will introduce Colgate Max Fresh Cool Scrub and Colgate Sensitive SmartFoam with Whitening in the third quarter, firm announces July 24. Launches will build on momentum generated by oral-care entries in the second quarter, when North American sales climbed 5%.

In Brief

As part of its mission to “better control and prepare for hazards,” FDA’s Center for Food Safety and Applied Nutrition aims to get a firmer handle on the safety of nanoparticles in cosmetics. More news in brief.

Colgate Targets Premium, “Super-Premium” Segments For U.S. Growth

Colgate-Palmolive looks to capture U.S. oral-care share with high-end innovations in the mouthwash and toothbrush categories. A the Barclays Americas Select Franchise Conference, Colgate president North America and global sustainability says the firm expects to build awareness quickly for Colgate Total Pro-Shield mouthwash, while preparing to launch a toothbrush that makes brushing “exciting.”

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018499

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel